A perspective on the ESVEM trial and current knowledge: Sotalol should not be the first-line agent in the management of ventricular arrhythmias

Progress in Cardiovascular Diseases

Volumn 38, Issue 6, 1996, Pages 455-456

  Garan, H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; SOTALOL;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG CHOICE; DRUG EFFICACY; DRUG PROTEIN BINDING; HEART VENTRICLE TACHYCARDIA; HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SECONDARY PREVENTION; TREATMENT OUTCOME;

EID: 0029996655     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-0620(96)80009-0     Document Type: Article

References (12)

1. Nademanee K Singh BN Effects of sotalol on ventricular tachycardia and fibrillation produced by programmed electrical stimulation: Comparison with other antiarrhythmic agents Am J Cardiol 65 1990 53A 57A
2. Kehoe RF MacNeil DJ Zheutlin TA Safety and efficacy of oral sotalol for sustained ventricular tachyarrhythmias refractory to other antiarrhythmic agents Am J Cardiol 72 1993 56A 66A
3. Kuchar DL Garan H Venditti FJ Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts Am J Cardiol 64 1989 33 36
4. for the Electrophysiologic Study versus Electrocardiographic Monitoring Investigators Mason JW A comparison of electrophysiologic testing with holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias N Engl J Med 329 1993 445 451
5. for the Electrophysiologic Study versus Electrocardiocardiographic Monitoring Investigators Mason JW A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias N Engl J Med 329 1993 452 458
6. Cardiac Arrhythmias Suppression Trial (CAST) Investigators Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction N Engl J Med 321 1989 406 412
7. Amiodarone Versus Sotalol Study Group Multicentre randomised trial of sotalol vs amiodarone for chronic malignant ventricular tachyarrhythmias Eur Heart J 10 1989 685 694
8. Man KC Williamson BD Niebauer M Electrophysiologic effects of sotalol and amiodarone in patients with sustained monomorphic ventricular tachycardia Am J Cardiol 74 1994 1119 1123
9. Fitton A Sorkin EM Sotalol: An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias Drugs 46 1993 678 719
10. Soyka LF Wirtz C Spangenberg RB Clinical safety profile of sotalol in patients with arrhythmias Am J Cardiol 65 1990 74A 81A
11. (abstr) Rankin AC Hamilton L Du D Predictors of inducible arrhythmia suppression and long term efficacy of oral sotalol in patients with drug refractory ventricular arrhythmias Br Heart J 66 1991 108A
12. Young GD Kerr CR Mohama R Efficacy of sotalol guided by programmed electrical sitmulation for sustained ventricular arrhythmias secondary to coronary artery disease Am J Cardiol 73 1994 677 682